Live Markets »News & Advice»Market News»Market News Details
Market News Details

Piramal Enterprises' partner launches kidney ailment drug in US markets

BS Reporter/ 12 Mar 19 | 11:02 PM

Representative Image | Photo: Shutterstock

Piramal Enterprises said on Tuesday one of its partners for global business, Slate Run Pharmaceuticals, had launched generic versions of Cinacalcet hydrochloride tablets in the US in three dosage strengths. The drug, which has a market size of $1.7 billion, is used for treatment of chronic kidney disease. The launch comes at a time when US-based Amgen has challenged Piramal’s licence to make a bio-equivalent version of the drug. 

Related Stories

    No Related Stories Found
Widgets Magazine

This is the first major launch by Piramal Pharma Solutions through a partner.   "We are working with global firms to co-develop products, where our R&D competencies can bring about a cost-effective value proposition for the global health care system," said Vivek Sharma, CEO, Piramal Pharma Solutions. 

Widgets Magazine


Company Price Gain (%)
ICICI Bank431.505.09
Larsen & Toubro1,543.654.60
Bharti Airtel353.304.40
Tata Motors182.154.09


Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine